“…29 With regard to the heterogeneity of diagnoses, the majority of studies examined survivors of all cancers, with seven studies excluding central nervous system malignancies, 17,19,22,25,31,34,38 and only one focusing on Hodgkin's lymphoma survivors. 29 The majority (number [n] =14) of studies examined both PTSS and PTSD outcomes; five assessed PTSD alone 16,18,25,36,37 and four evaluated PTSS alone. 22,27,34,38 Sample sizes ranged from 23-6,542, with ten samples of less than 100, 17,19,[23][24][25][30][31][32]36 eleven samples between 100 and 350, 18,20,22,26,29,[33][34][35]37,38 and two samples exceeding 6,500.…”